United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - major depressive disorder: bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of inpatients and in one 6-week controlled trial of outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical trials). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration,

Canada - English - Health Canada

solvay pharma inc - eprosartan (eprosartan mesylate) - tablet - 300mg - eprosartan (eprosartan mesylate) 300mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

solvay pharma inc - betahistine hydrochloride - tablet - 8mg - betahistine hydrochloride 8mg - miscellaneous therapeutic agents

Canada - English - Health Canada

solvay pharma inc - dronabinol - capsule - 10mg - dronabinol 10mg - miscellaneous antiemetics

United States - English - NLM (National Library of Medicine)

stat rx usa llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - major depressive disorder: bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of inpatients and in one 6-week controlled trial of outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical trials). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired c

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

solvay interox pty. ltd. - hydrogen peroxide; acetic acid; peroxyacetic acid - aqueous concentrate - hydrogen peroxide ungrouped active 282.0 g/l; acetic acid acid-general active 85.0 g/l; peroxyacetic acid acid-general active 56.0 g/l - disinfectant - food processing and/or preserving plant | pharmaceutical plant | processing and manufacturing plants - bacteria | bacterial spore | fungal spore | fungus | fungal leaf spots | fungi | fungus diseases | leaf spot diseases | leaf spots

United States - English - NLM (National Library of Medicine)

stat rx usa llc - bupropion hydrobromide (unii: e70g3g5863) (bupropion - unii:01zg3tpx31) - bupropion hydrobromide 348 mg - aplenzin™ (bupropion hydrobromide extended-release tablets) is indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of inpatients and in one 6-week controlled trial of outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) [see clinical studies (14) ] . a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide atte

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - prometrium capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. prometrium capsules should not be used in women with any of the following conditions: - prometrium capsules should not be used in patients with known hypersensitivity to its ingredients. prometrium capsules contain peanut oil and should never be used by patients allergic to peanuts. - undiagnosed abnormal genital bleeding. - known, suspected, or history of cancer of the breast. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction). - liver dysfunction or disease. - known or suspected pregnancy. there is no indication for prometrium capsules in pregnancy. there appears to be little or no increased risk of birth defects in chi

Canada - English - Health Canada

solvay pharma inc - potassium chloride; sodium phosphate dibasic; calcium chloride; magnesium chloride; sodium chloride - spray - 1.2mg; 0.28mg; 0.15mg; 0.05mg; 0.05mg - potassium chloride 1.2mg; sodium phosphate dibasic 0.28mg; calcium chloride 0.15mg; magnesium chloride 0.05mg; sodium chloride 0.05mg - eent drugs, miscellaneous

Canada - English - Health Canada

solvay pharma inc - potassium chloride; sodium phosphate dibasic; calcium chloride; magnesium chloride; sodium chloride - liquid - 1.2mg; .28mg; .15mg; .05mg; .05mg - potassium chloride 1.2mg; sodium phosphate dibasic .28mg; calcium chloride .15mg; magnesium chloride .05mg; sodium chloride .05mg - eent drugs, miscellaneous